Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-25-096735
Filing Date
2025-07-17
Accepted
2025-07-17 20:45:26
Documents
1
Period of Report
2025-07-15

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 3449
  Complete submission text file 0000950170-25-096735.txt   4913
Mailing Address 1 CASPER STREET DANBURY CT 06810
Business Address 1 CASPER STREET DANBURY CT 06810 818-661-5000
MANNKIND CORP (Issuer) CIK: 0000899460 (see all company filings)

EIN.: 133607736 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 1900 POWELL STREET SUITE 750 EMERYVILLE CA 94608
Business Address
Prentiss Christopher B (Reporting) CIK: 0001717583 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-50865 | Film No.: 251132484